RG
Gedeon Richter PLC
RGEDF · OTC
$41.03 -1.11% (-$0.46)
1M -1.87%
Market Cap 2.32T Ft
P/E Ratio 10.83x
Div. Yield 5.34%
ROE 15.52%
Bulios Fair Price
$49.95
21.8% upside
Current Price
$41.03
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RGEDF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
96 /100
Cheap P/E 10.83x
EV/EBITDA 5.47x
P/S 2.53x
Growth
72 /100
Growing EPS growth 14.82%
Rev. growth 4.78%
FCF growth 29.87%
Profitability
100 /100
Strong Gross margin 68.47%
Net margin 23.37%
Op. margin 35.39%
Quality
80 /100
Excellent ROIC 17.84%
ROE 15.52%
ROA 12.67%
Debt
88 /100
Low Debt/Equity 0.01x
Current ratio 3.79x
Int. coverage 3.27x
Stability
74 /100
Stable Beta 0.34x
Rev. volatility 3.97%
EPS volatility 30.30%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RGEDF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Gabor Orban
Employees
11,955
Headquarters
Budapest
Upcoming events
10 NOV
Earnings
Upcoming earnings report